Enhanced signaling and morphological transformation by a membrane- localized derivative of the fibroblast growth factor receptor 3 kinase domain

Molecular and Cellular Biology

Volumn 17, Issue 10, 1997, Pages 5739-5747

  Webster, Melanie K ^a   Donoghue, Daniel J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STRAIN 3T3; CELL TRANSFORMATION; CONTROLLED STUDY; MITOGENESIS; MOUSE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0030764173     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.10.5739     Document Type: Article

References (64)

1. Adnane, J., P. Gaudray, C. A. Dionne, G. Crumley, M. Jaye, J. Schlessinger, P. Jeanteur, D. Birnbaum, and C. Theillet. 1991. BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene 6:659-663.
2. Aronheim, A., D. Engelberg, N. Li, N. al-Alawi, J. Schlessinger, and M. Karin. 1994. Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway. Cell 78:949-961.
3. Bargmann, C. I., M. C. Hung, and R. A. Weinberg. 1986. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45:649-657.
4. Basilico, C., and D. Moscatelli. 1992. The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59:115-165.
5. Bongarzone, I., N. Monzini, M. G. Borrello, C. Carcano, G. Ferraresi, E. Arighi, P. Mondellini, G. Della Porta, and M. A. Pierotti. 1993. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulalory subunit RI alpha of cyclic AMP-dependcnt protein kinase A. Mol. Cell. Biol. 13:358-366.
6. v-ras. Mol. Cell. Biol. 8:3960-3963.
7. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
8. Chesi, M., E. Nardini, L. A. Brents, E. Schrock, T. Ried, W. M. Kuehl, and P. L. Bergsagel. 1997. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma: association with increased expression and activating mutations of fibroblast growth factor receptor 3. Nature Genet., 16:260-264.
9. Curtis, B. M., M. B. Widmer, P. deRoos, and E. E. Qwarnstrom. 1990. IL-1 and its receptor are translocated to the nucleus. J. Immunol. 144:1295-1303.
10. Delli Bovi, P., A. M. Curatola, F. G. Kern, A. Greco, M. Ittmann, and C. Basilico. 1987. An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell 50:729-737.
11. Friesel, R. E., and T. Maciag. 1995. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J. 9:919-925.
12. Goldfarb, M., R. Deed, D. MacAllan, W. Walther, C. Dickson, and G. Peters. 1991. Cell transformation by Int-2 - a member of the fibroblast growth factor family. Oncogene 6:65-71.
13. Golub, T. R., G. F. Barker, M. Lovett, and D. G. Gilliland. 1994. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocalion. Cell 77:307-316.
14. Hattori, Y., H. Odagiri, H. Nakatani, K. Miyagawa, K. Naito, H. Sakamoto, O. Katoh, T. Yoshida, T. Sugimura, and M. Terada. 1990. K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc. Natl. Acad. Sec. USA 87:5983-5987.
15. Hayman, M. J., and P. J. Enrietto. 1991. Cell transformation by the epidermal growth factor receptor and v-erbB. Cancer Cells 3:302-307.
16. Horlick, R. A., S. L. Stack, and G. M. Cooke. 1992. Cloning, expression and tissue distribution of the gene encoding rat fibroblast growth factor receptor subtype 4. Gene 120:291-295.
17. Hou, J. Z., M. K. Kan, K. McKeehan, G. McBride, P. Adams, and W. L. McKeehan. 1991. Fibroblast growth factor receptors from liver vary in three structural domains. Science 251:665-668.
18. Hu, Q., D. Milfay, and L. T. Williams. 1995. Binding of NCK to SOS and activation of ras-dependent gene expression. Mol. Cell. Biol. 15:1169-1174.
19. Imamura, T., K. Engleka, X. Zhan, Y. Tokita, R. Forough, D. Roeder, A. Jackson, J. A. Maier, T. Hla, and T. Maciag. 1990. Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. Science 249:1567-1570.
20. Jans, D. A. 1994. Nuclear signaling pathways for polypeptide ligands and their membrane receptors? FASEB J. 8:841-847.
21. Jaye, M., J. Schlessinger, and C. A. Dionne. 1992. Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim. Biophys. Acta 1135:185-199.
22. Jiang, L. W., and M. Schindler. 1990. Nucleocytoplasmic transport is enhanced concomitant with nuclear accumulation of epidermal growth factor (EGF) binding activity in both 3T3-1 and EGF receptor reconstituted NR-6 fibroblasts. J. Cell Biol. 110:559-568.
23. Johnson, D. E., and L. T. Williams. 1993. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60:1-41.
24. Johnston, C. L., H. C. Cox, J. J. Gomm, and R. C. Coombes. 1995. Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. A splice variant of FGFR-3 localizes to the nucleus. J. Biol. Chem. 270: 30643-30650.
25. 2-terminal glycine of p60src prevents both myristoylation and morphological transformation. Proc. Natl. Acad. Sci. USA 82:4625-4628.
26. Kan, M., F. Wang, B. To, J. L. Gabriel, and W. L. McKeehan. 1996. Divalent cations and heparin/heparan sulfate cooperate to control assembly and activity of the fibroblast growth factor receptor complex. J. Biol. Chem. 271: 26143-26148.
27. Kanai, M., M. Goke, S. Tsunekawa, and D. K. Podolsky. 1997. Signal transduction pathway of human fibroblast growth factor receptor 3. Identification of a novel 66-kDa phosphoprotein. J. Biol. Chem. 272:6621-6628.
28. Kobrin, M. S., Y. Yamanaka, H. Friess, M. E. Lopez, and M. Korc. 1993. Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas. Cancer Res. 53:4741-4744.
29. Kouhara, H., S. Kurebayashi, K. Hashimoto, S. Kasayama, M. Koga, T. Kishimoto, and B. Sato. 1995. Ligand-independent activation of tyrosine kinase in fibroblast growth factor receptor 1 by fusion with beta-galactosidase. Oncogene 10:2315-2322.
30. Leevers, S. J., H. F. Paterson, and C. J. Marshall. 1994. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane Nature 369:411-414.
31. Lobie, P. E., T. J. Wood, C. M. Chen, M. J. Waters, and G. Norstedt. 1994. Nuclear translocation and anchorage of the growth hormone receptor. J. Biol. Chem. 269:31735-31746.
32. Lorenzi, M. V., Y. Horii, R. Yamanaka, K. Sakaguchi, and T. Miki. 1996. Frag1, a gene that potently activates fibroblast growth factor receptor by C-terminal fusion through chromosomal rearrangement. Proc. Natl. Acad Sci. USA 93:8956-8961.
33. MacArthur, C. A., A. Lawshe, D. B. Shankar, M. Heikinheimo, and G. M. Shackleford. 1995. FGF-8 isoforms differ in NIH3T3 cell transforming potential. Cell Growth Differ. 6:817-825.
34. Maher, P. A. 1996. Identification and characterization of a novel, intracellular isoform of fibroblast growth factor receptor-1 (Fgfr-1). J. Cell. Physiol. 169:380-390.
35. Maher, P. A. 1996. Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2. J. Cell Biol. 134:529-536.
36. Marics, I., J. Adelaide, F. Raybaud, M. G. Mattel, F. Coulier, J. Planche, O. de Lapeyriere, and D. Birnbaum. 1989. Characterization of the HST-related FGF6 gene, a new member of the fibroblast growth factor gene family. Oncogene 4:335-340.
37. Mohammadi, M., J. Schlessinger, and S. R. Hubbard. 1996. Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 86:577-587.
38. Muenke, M., and U. Schell. 1995. Fibroblast-growth-factor receptor mutation in human skeletal disorders. Trends Genet. 11:308-313.
39. Nakamoto, T., C. S. Chang, A. K. Li, and G. W. Chodak. 1992. Basic fibroblast growth factor in human prostate cancer cells. Cancer Res. 52:571-577.
40. Park, W. J., G. A. Bellus, and E. W. Jabs. 1995. Mutations in fibroblast growth factor receptors: phenotypic consequences during eukaryotic development. Am. J. Hum. Genet. 57:748-754.
41. Peters, K., D. Ornitz, S. Werner, and L. Williams. 1993. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev. Biol. 155:423-430.
42. Podlecki, D. A., R. M. Smith, M. Kao, P. Tsai, T. Huecksteadt, D. Brandenburg, R. S. Lasher, L. Jarett, and J. M. Olefsky. 1987. Nuclear translocalion of the insulin receptor. A possible mediator of insulin's long term effects. J. Biol. Chem. 262:3362-3368.
43. Prudovsky, I., N. Savion, X. Zhan, R. Friesel, J. Xu, J. Hou, W. L. McKeehan, and T. Maciag. 1994. Intact and functional fibroblast growth factor (FGF) receptor-1 trafficks near the nucleus in response to FGF-1. J. Biol. Chem. 269:31720-31724.
44. Prudovsky, I. A., N. Savion, T. M. La Vallee, and T. Maciag. 1996. The nuclear trafficking of extracellular fibroblast growth factor (FGF)-1 correlates with the perinuclear association of the FGF receptor-1alpha isoforms but not the FGF receptor-1beta isoforms. J. Biol. Chem. 271:14198-14205.
45. Robbins, J., S. M. Dilworth, R. A. Laskey, and C. Dingwall. 1991. Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell 64:615-623.
46. Rodrigues, G. A., and M. Park. 1993. Dimerization mediated through a leucine zipper activates the oncogenic potential of the Met receptor tyrosine kinase. Mol. Cell. Biol. 13:6711-6722.
47. Rousseau, F., V. el Ghouzzi, A. L. Delezoide, L. Legeai-Mallet, M. Le Merrer, A. Munnich, and J. Bonaventure. 1996. Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TDI). Hum. Mol. Genet. 5:509-512.
48. Sawyers, C. L., and C. T. Denny. 1994. Chronic myelomonocytic leukemia: Tel-a-kinase what Ets all about. Cell 77:171-173.
49. Shu, H. K., R. J. Pelley, and H. J. Kung. 1990. Tissue-specific transformation by epidermal growth factor receptor: a single point mutation within the ATP-hinding pocket of the erbB product increases its intrinsic kinase activity and activates its sarcomagenic potential. Proc. Natl. Acad. Sci. USA 87: 9103-9107.
50. Spivak-Kroizman, T., M. A. Lemmon, I. Dikic, J. E. Ladbury, D. Pinchasi, J. Huang, M. Jaye, G. Crumley, J. Schlessinger, and I. Lax. 1994. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79:1015-1024.
51. Su, W. C., M. Kitagawa, N. Xue, B. Xie, S. Garofalo, J. Cho, C. Deng, W. A. Horton, and X. Y. Fu. 1997. Activation of Stat 1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386:288-292.
52. Takahashi, J. A., H. Mori, M. Fukumoto, K. Igarashi, M. Jaye, Y. Oda, H. Kikuchi, and M. Hatanaka. 1990. Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc. Natl. Acad. Sci. USA 87:5710-5714.
53. Tavormina, P. L., R. Shiang, L. M. Thompson, Y. Z. Zhu, D. J. Wilkin, R. S. Lachman, W. R. Wilcox, D. L. Rimoin, D. H. Cohn, and J. J. Wasmuth. 1995. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat. Genet. 9:321-328.
54. Tavormina, P. L., G. A. Bellus, M. K. Webster, M. J. Bamshad, A. E. Fraley, I. McIntosh, J. Szabo, W. Jiang, E. W. Jabs, W. R. Wilcox, J. J. Wasmuth, D. J. Donoghue, L. M. Thompson, and C. A. Francomano. Thanatophoric dysplasia type II and a unique skeletal dysplasia with acanthosis nigricans and mental retardation are caused by two different point mutations within codon 650 of the fibroblast growth factor receptor 3 (FGFR3) gene. Submitted for publication.
55. Theillet, C., X. Le Roy, O. De Lapeyriere, J. Grosgeorges, J. Adnane, S. D. Raynaud, J. Simony-Lafontaine, M. Goldfarb, C. Escot, and D. Birnbaum. 1989. Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas. Oncogene 4:915-922.
56. Webster, M. K., P. Y. D'Avis, S. C. Robertson, and D. J. Donoghue. 1996. Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II. Mol. Cell. Biol. 16:4081-4087.
57. Webster, M. K., and D. J. Donoghue. 1996. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 15:520-527.
58. Webster, M. K., and D. J. Donoghue. 1997. FGFR activation in skeletal disorders: too much of a good thing. Trends Genet. 13:178-182.
59. Wiedlocha, A., P. O. Falnes, I. H. Madshus, K. Sandvig, and S. Olsnes. 1994. Dual mode of signal transduction by externally added acidic fibroblast growth factor. Cell 76:1039-1051.
60. Yamaguchi, F., H. Saya, J. M. Bruner, and R. S. Morrison. 1994. Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc. Natl. Acad. Sci. USA 91:484-488.
61. Yamanaka, Y., H. Friess, M. Buchler, H. G. Beger, E. Uchida, M. Onda, M. S. Kobrin, and M. Korc. 1993. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res. 53:5289-5296.
62. Yan, G., Y. Fukabori, G. McBride, S. Nikolaropolous, and W. L. McKeehan. 1993. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol. Cell. Biol. 13:4513-4522.
63. Zhan, X., X. Hu, R. Friesel, and T. Maciag. 1993. Long term growth factor exposure and differential tyrosine phosphorylation are required for DNA synthesis in BALB/c 3T3 cells. J. Biol. Chem. 268:9611-9620.
64. Zhan, X., B. Bates, X. G. Hu, and M. Goldfarb. 1988. The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors. Mol. Cell. Biol. 8:3487-3495.